Product Name | MF | CAS | Details |
---|
Phthalamic Acid | C28H34O15 | 520-26-3 | Details |
Noradrenaline Impurity 64 | C20H24BrFN2O2 | 103146-26-5 | Details |
DL-Methionine Sulfoxide | C14H15N3O5 | 145195-63-7 | Details |
Tofacitinib Citrate | C6H13NO2 | 60-32-2 | Details |
Linagliptin Impurity CD10138 | C15H13NO4S | 794510-29-5 | Details |
Cilnidipine Impurity 58 | C14H20BrClN2 | 32193-43-4 | Details |
(R)-Amlodipine | C12H17N3O.ClH | 132036-42-1 | Details |
Tofacitinib Citrate | C11H13NO | 96686-24-7 | Details |
Nintedanib Impurity 71 | C13H15NO5S | 118854-48-1 | Details |
Deubutafrazine Impurity | C11H11NO5S | 35511-15-0 | Details |
Phthalamic Acid | C8H11ClN2O2 | 131020-57-0 | Details |
1,3-dimethyl-46-nitrosourea | C13H17NO | 64011-89-8 | Details |
Lactate tetramer | C9H7NO2 | 31570-97-5 | Details |
2-hydroxy-49-(methylthio)butanamide | C7H6O5S | 632-25-7 | Details |
Valsartan Methyl Ester | C10H13NO | 13936-60-2 | Details |
Noradrenaline Impurity 60 | C12H15NO | 127345-12-4 | Details |
Varenicline Impurity D | C7H13NO3S | 1115-47-5 | Details |
Vitamin B6 Impurity 100 | 124538-05-2 | Details |
2-hydroxy-52-(methylthio)butanamide | C9H15NO3 | 1599413-49-6 | Details |
Linagliptin Impurity CD10137 | C16H30N2O6 | 927-89-9 | Details |
Deubutafrazine Impurity | C17H17NO3S2 | 682775-71-9 | Details |
Ezetimibe (SSR)-Isomer | C7H6N2O4 | 619-17-0 | Details |
Ezetimibe (SSR)-Isomer | C21H23ClN2O7 | 6625-20-3 | Details |
Baricitinib Impurity I | C14H11NO3S2 | 1800597-47-0 | Details |
2-hydroxy-53-(methylthio)butanamide | C9H11NO3 | 2370-61-8 | Details |
Baricitinib Impurity I | C21H25NO4 | 112242-15-6 | Details |
1,3-dimethyl-49-nitrosourea | C11H14O | 191543-16-5 | Details |
Valsartan Methyl Ester | C12H16O2 | 132489-33-9 | Details |
(R)-Amlodipine | C9H14BN | 93830-58-1 | Details |
Vitamin B6 Impurity 98 | C6H8N2O8 | 87-33-2 | Details |
Varenicline Impurity D | C24H38O4 | 24637-46-5 | Details |
Lactate tetramer | C15H23ClN2O | 101152-94-7 | Details |
Noradrenaline Impurity 63 | C13H13N3O6 | 295357-73-2 | Details |
Varenicline Impurity D | C18H20N2O2 | 86891-15-8 | Details |
Noradrenaline Impurity 62 | C10H12ClNO2 | 1134-47-0 | Details |
DL-Methionine Sulfoxide | C7H13NO2 | 6778-30-9 | Details |
Linagliptin Impurity CD10134 | C6H2F4 | 551-62-2 | Details |
(R)-Amlodipine | C24H38O2 | 119818-40-5 | Details |
Valsartan Methyl Ester | C3H4N2 | 288-13-1 | Details |
Vitamin B6 Impurity 97 | C9H9N | 603-76-9 | Details |
Valsartan Methyl Ester | C13H14BrClN4O2S | 1393813-42-7 | Details |
1,3-dimethyl-52-nitrosourea | C22H20ClFN4O4 | 2121530-37-6 | Details |
2-hydroxy-56-(methylthio)butanamide | C3 H6 N2 O2 S | 317806-76-1 | Details |
Baricitinib Impurity I | C22H36N2O5S | 144494-65-5 | Details |
Nintedanib Impurity 77 | C40H27F8N9O4S | 2894796-77-9 | Details |
Fulvestrant Impurity I | C18H19NO3 | 720685-14-3 | Details |
Phthalamic Acid | C16H20ClNO3 | 2460133-49-5 | Details |
Fulvestrant Impurity I | C7H3Cl2NO3 | 7073-36-1 | Details |
Cilnidipine Impurity 59 | C24H21F2NO3 | 2743547-96-6 | Details |
Varenicline Impurity D | C11H6ClFN2 | 1240948-72-4 | Details |
Baricitinib Impurity I | C13H7ClFIO | 2452301-23-2 | Details |
Fulvestrant Impurity I | C12H13F3O2 | 70311-33-0 | Details |
Rosuvastatin EP Impurity A | C18H21ClO4S | 1985682-45-8 | Details |
Noradrenaline Impurity 67 | C13H12F2N4O | 241479-74-3 | Details |
1,3-dimethyl-53-nitrosourea | C9H9NO4 | 113579-20-7 | Details |
Fulvestrant Impurity I | C29H28F4N4O4 | 917389-37-8 | Details |
N-Nitroso Furosemide | C12H18O2 | 1822329-44-1 | Details |
Vitamin B6 Impurity 104 | C15H28N4O4 | 2758048-72-3 | Details |
Nintedanib Impurity 78 | C22H30N6O2S | 2478551-43-6 | Details |
DL-Methionine Sulfoxide | C18H22N4O3 | 1456520-25-4 | Details |
Varenicline Impurity D | C12H18BrNO2 | 164519-76-0 | Details |
Rosuvastatin EP Impurity A | C19H26O2 | 133177-83-0 | Details |
Valsartan Methyl Ester | C28H33N7O3 | 1975982-94-5 | Details |
Phthalamic Acid | C19H21BrN6O4S | 2211059-00-4 | Details |
Fulvestrant Impurity I | C20H18O10 | 50583-51-2 | Details |
Rosuvastatin EP Impurity A | C24H40O4 | 570-62-7 | Details |
Baricitinib Impurity I | C18H15ClN2OS | 316149-01-6 | Details |
N-Nitroso Furosemide | C69H98O6 | 11094-59-0 | Details |
N-Nitroso Furosemide | C24H19F2N3O4S | 1985605-59-1 | Details |
N-Nitroso Furosemide | C6H11N3O4 | 556-33-2 | Details |
Varenicline Impurity D | C28H31N3O6.HCl | 91599-74-5 | Details |
1,3-dimethyl-47-nitrosourea | C16H18N2O | 503598-78-5 | Details |
Noradrenaline Impurity 65 | C15H24O3 | 6485-57-0 | Details |
Valsartan Methyl Ester | C18H18O5 | 38302-15-7 | Details |
Rosuvastatin EP Impurity A | C17H25N5O2 | 2514953-93-4 | Details |
Baricitinib Impurity I | C6H3Cl2NO3 | 618-80-4 | Details |
Rosuvastatin EP Impurity A | C4H7NO2 | 5977-14-0 | Details |
1,3-dimethyl-48-nitrosourea | C27H30O14 | 552-57-8 | Details |
Varenicline Impurity D | C30H31F2N3O4S | 2136287-69-7 | Details |
Ezetimibe (SSR)-Isomer | C22H26O4 | 1809224-82-5 | Details |
Tofacitinib Impurity FD+DX | C18H22N2S | 508233-77-0 | Details |
Vitamin B6 Impurity 102 | C4H8N2O3 | 556-50-3 | Details |
Fulvestrant Impurity I | C15H14O3 | 21409-25-6 | Details |
Noradrenaline Impurity 68 | C19H19N3O3 | 2407652-86-0 | Details |
Linagliptin Impurity CD10141 | C8H15N3O4 | 1402135-14-1 | Details |
DL-Methionine Sulfoxide | C20H21N3O2S | 646459-39-4 | Details |
Baricitinib Impurity I | C16H18O3 | 19574-66-4 | Details |
Varenicline Impurity D | C17H17N3O | 132036-90-9 | Details |
Lactate tetramer | C29H55NO6 | 2088879-81-5 | Details |
Valsartan Methyl Ester | C29H28F4N4O5 | 2991059-71-1 | Details |
Valsartan Methyl Ester | C21H28N6O4S | 1838-39-8 | Details |
Ezetimibe (SSR)-Isomer | C21H16ClN3O2S | 2305694-79-4 | Details |
Nintedanib Impurity 70 | C17H13ClN2O2S | 202409-31-2 | Details |
Ezetimibe (SSR)-Isomer | C18H22O6 | 96259-88-0 | Details |
Vitamin B6 Impurity 105 | C18H14Cl4N2O | 27523-40-6 | Details |
Cilnidipine Impurity 61 | C16H20N2O4 | 55855-45-3 | Details |
Phthalamic Acid | C25H28BrNO4S2 | 320346-75-6 | Details |
Varenicline Impurity D | C9H9F2N | 1511636-19-3 | Details |
1,3-dimethyl-54-nitrosourea | C20H25NO3 | 153037-40-2 | Details |
Linagliptin Impurity CD10135 | C15H20ClNO | 1353644-50-4 | Details |
Product Total: Product Page: | ||||
100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 |